Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,175.37, giving the company a market capitalization of 1.11T. It carries a P/E multiple of 40.42 and pays a dividend yield of 0.54%.
On 2026-08-28, Eli Lilly(LLY) stock traded between a low of $1,171.71 and a high of $1,190.89. Shares are currently priced at $1,175.37, which is +0.3% above the low and -1.3% below the high.
The Eli Lilly(LLY)'s current trading volume is 2.73M, compared to an average daily volume of 2.58M.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
LLY News
Shares of Eli Lilly (LLY) are pulling back after hitting an all-time high. The pharmaceutical company’s stock has dropped 4% in the past week after reaching a r...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The phase 3 study “A Phase 3, Randomized, Double-Blind Study to Investigate th...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The Phase 3 RENEW-MDD-2 study from Eli Lilly And Company tests brenipatide as...
Analyst ratings
82%
of 33 ratingsMore LLY News
Eli Lilly (NYSE: LLY) reported new independent real-world evidence that its obesity treatment Zepbound (tirzepatide) is linked to lower overall healthcare costs...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly and Co. (LLY) has launched a Phase 1 trial titled “A Placebo-Control...
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s (LLY) new blood test that helps to identify signs of Alzheimer’s disease in people aged 55...
Key Points Obesity drugs like Mounjaro and Zepbound could help the drugmaker power ahead for years. Its Alzheimer’s drug Kisunla and broad pipeline add anothe...
The Fidelity MSCI Health Care Index ETF (FHLC +0.47%) provides broad, low-cost exposure to the entire healthcare sector, whereas the VanEck Pharmaceutical ETF (...
Eli Lilly (LLY) announced results from a real-world study of adults over 55 with overweight or obesity, which found that staying on Zepbound for weight manageme...
Eli Lilly stock has logged very strong gains over the past few years, yet the latest valuation checks send a mixed message about where fair value may sit. The i...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.